Full Press Release Details
Announces Completion of "Stock
DUBLIN, Ireland--(BUSINESS WIRE)--ICON (NASDAQ: ICLR) (ISIN:
IE0005711209), a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries,
today announced that it has completed its bonus issue of ordinary shares
(or ADSs). The effect of the bonus issue of one new ordinary share (or
ADS) to the holder of each existing ordinary share (or ADS) of record on
August 8, 2008 is the equivalent of a 2-for-1 stock split.
The bonus shares were issued to holders of ADSs on August 12, 2008.
NASDAQ adjusted the trading price of ICON's ADSs to effect the Bonus
Issue prior to the opening of trading on August 13, 2008.
ICON is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. We
specialize in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON
currently operates from 71 locations in 38 countries and has
approximately 6,500 employees. Further information is available at www.iconplc.com
The statements made in this Press Release may contain forward-looking
statements that involve a number of risks and uncertainties. In addition
to the matters described in this Press Release, the ability to maintain
large client contracts or enter into new contracts, maintain client
relationships and the ability to manage the opening of new offices, the
integration of new business mergers and acquisitions, as well as other
risks and uncertainties detailed from time to time in SEC reports filed
by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the
actual results achieved by ICON. ICON disclaims any intent or obligation
to update these forward-looking statements.
Investor Relations, 1-888-381-7923
Murray, CFO, +353-1-291-2000